Recombinant multi-species EPO/Erythropoietin protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EPO/Erythropoietin protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies. [provided by RefSeq, Aug 2017]
The Alternative Names of target: DBAL,ECYT5,EP,EPO,Epo,Erythropoietin,MVCD2
Go
to EPO/Erythropoietin products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T07958-Ag-1/ GM-Tg-hg-T07958-Ag-2 | Human EPO/Erythropoietin protein | Human |
| GM-Tg-rg-T07958-Ag-1/ GM-Tg-rg-T07958-Ag-2 | Rat EPO/Erythropoietin protein | Rat |
| GM-Tg-mg-T07958-Ag-1/ GM-Tg-mg-T07958-Ag-2 | Mouse EPO/Erythropoietin protein | Mouse |
| GM-Tg-cynog-T07958-Ag-1/ GM-Tg-cynog-T07958-Ag-2 | Cynomolgus/Rhesus macaque EPO/Erythropoietin protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T07958-Ag-1/ GM-Tg-felg-T07958-Ag-2 | Feline EPO/Erythropoietin protein | Feline |
| GM-Tg-cang-T07958-Ag-1/ GM-Tg-cang-T07958-Ag-2 | Canine EPO/Erythropoietin protein | Canine |
| GM-Tg-bovg-T07958-Ag-1/ GM-Tg-bovg-T07958-Ag-2 | Bovine EPO/Erythropoietin protein | Bovine |
| GM-Tg-equg-T07958-Ag-1/ GM-Tg-equg-T07958-Ag-2 | Equine EPO/Erythropoietin protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T07958-Ag-1/ GM-Tg-hg-T07958-Ag-2;
GM-Tg-rg-T07958-Ag-1/ GM-Tg-rg-T07958-Ag-2;
GM-Tg-mg-T07958-Ag-1/ GM-Tg-mg-T07958-Ag-2; GM-Tg-cynog-T07958-Ag-1/ GM-Tg-cynog-T07958-Ag-2; GM-Tg-felg-T07958-Ag-1/ GM-Tg-felg-T07958-Ag-2; GM-Tg-cang-T07958-Ag-1/ GM-Tg-cang-T07958-Ag-2; GM-Tg-bovg-T07958-Ag-1/ GM-Tg-bovg-T07958-Ag-2; GM-Tg-equg-T07958-Ag-1/ GM-Tg-equg-T07958-Ag-2 |
| Products Name | EPO/Erythropoietin protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | EPO/Erythropoietin |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EPO/Erythropoietin protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.